Eline M. Loosveld

420 total citations
5 papers, 173 citations indexed

About

Eline M. Loosveld is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Eline M. Loosveld has authored 5 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Molecular Biology. Recurrent topics in Eline M. Loosveld's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cholinesterase and Neurodegenerative Diseases (1 paper). Eline M. Loosveld is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cholinesterase and Neurodegenerative Diseases (1 paper). Eline M. Loosveld collaborates with scholars based in . Eline M. Loosveld's co-authors include Patrick G. Groothuis, David Egging, Miranda M.C. van der Lee, Ruud Ubink, Wim H.A. Dokter, Gijs Verheijden, Patrick H. Beusker, Marco Timmers, Daniëlle C.H. Jacobs and Diels van den Dobbelsteen and has published in prestigious journals such as Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Eline M. Loosveld

5 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eline M. Loosveld	3	149	125	39	18	12	5	173
Marco Timmers United States	3	138 0.9×	142 1.1×	65 1.7×	19 1.1×	9 0.8×	10	223
Josh Snyder United States	5	122 0.8×	77 0.6×	66 1.7×	16 0.9×	7 0.6×	6	189
Lillian Skidmore Italy	5	157 1.1×	133 1.1×	47 1.2×	39 2.2×	5 0.4×	11	192
Francesca Pettinella United States	4	75 0.5×	51 0.4×	29 0.7×	19 1.1×	6 0.5×	8	122
Sung-Ju Moon United States	3	153 1.0×	119 1.0×	77 2.0×	21 1.2×	5 0.4×	6	209
Ludivine Moine United States	3	130 0.9×	119 1.0×	90 2.3×	9 0.5×	8 0.7×	3	198
Bridget Chappell Australia	4	75 0.5×	96 0.8×	73 1.9×	19 1.1×	10 0.8×	7	154
Verónica Robles United States	5	125 0.8×	131 1.0×	65 1.7×	6 0.3×	2 0.2×	13	175
Jeffrey Lau United States	8	89 0.6×	68 0.5×	40 1.0×	10 0.6×	30 2.5×	12	155
Jennifer Shah United States	4	51 0.3×	45 0.4×	75 1.9×	67 3.7×	30 2.5×	4	193

Countries citing papers authored by Eline M. Loosveld

Since Specialization

Citations

This map shows the geographic impact of Eline M. Loosveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eline M. Loosveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eline M. Loosveld more than expected).

Fields of papers citing papers by Eline M. Loosveld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eline M. Loosveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eline M. Loosveld. The network helps show where Eline M. Loosveld may publish in the future.

Co-authorship network of co-authors of Eline M. Loosveld

This figure shows the co-authorship network connecting the top 25 collaborators of Eline M. Loosveld. A scholar is included among the top collaborators of Eline M. Loosveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eline M. Loosveld. Eline M. Loosveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Dokter, Wim H.A., Fred A. Dijcks, Patrick G. Groothuis, et al.. (2020). Abstract 4043: SYD985 synergy with PARP inhibitors (PARPi) in human tumor cell lines and patient-derived xenografts (PDXs). Cancer Research. 80(16_Supplement). 4043–4043. 1 indexed citations

2.

Ubink, Ruud, Ebo Bos, I. Janssen, et al.. (2018). Unraveling the Interaction between Carboxylesterase 1c and the Antibody–Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice. Molecular Cancer Therapeutics. 17(11). 2389–2398. 28 indexed citations

3.

Lee, Miranda M.C. van der, Patrick G. Groothuis, Ruud Ubink, et al.. (2015). The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers. Molecular Cancer Therapeutics. 14(3). 692–703. 141 indexed citations

4.

Groothuis, Patrick G., Ruud Ubink, Eline M. Loosveld, et al.. (2015). Abstract 5360: The preclinical profile of the duocarmycin-based HER2-targeting ADC SYD985 predicts for clinical benefit in low HER2-expressing breast cancers. Cancer Research. 75(15_Supplement). 5360–5360. 1 indexed citations

5.

Groothuis, Patrick G., Eline M. Loosveld, Daniëlle C.H. Jacobs, et al.. (2014). Abstract 2652: In vitro and in vivo antitumor activity of SYD985, a novel HER2-targeting ADC: a comparison with T-DM1. Cancer Research. 74(19_Supplement). 2652–2652. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact